Anus Diseases: Clinical Trials

361 trials for Anus Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

165 completed, 59 recruiting, 56 unknown, 28 terminated. 87 Not applicable, 87 Phase 2, 74 Phase 1, 32 Phase 3, 13 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable87Completed 40, Recruiting 21, Unknown 16, Not yet recruiting 7, Terminated 2, Active not recruiting 1
Phase 287Completed 34, Unknown 13, Recruiting 12, Active not recruiting 11, Terminated 9, Not yet recruiting 4, Withdrawn 3, Enrolling by invitation 1
Phase 174Completed 44, Terminated 10, Recruiting 8, Active not recruiting 4, Not yet recruiting 3, Unknown 3, Withdrawn 2
Phase 332Completed 17, Active not recruiting 6, Unknown 6, Recruiting 2, Terminated 1
Phase 413Completed 6, Unknown 3, Withdrawn 2, Recruiting 1, Terminated 1

Follow this condition Literature Review of Anus Diseases trials Research Report on Anus Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Improving Clinic Delivery of HIV-related Anal Health Services
PEACHES 2.0 Implementation Strategies - HIV, Gonorrhea
Not applicableNot yet recruitingAlbert Einstein College of Medicine82028-02-012026-10-13
COQ10 and Vitamin E for Off-Target Radiation Toxicity
Coenzyme Q10 Cap/Tab, Vitamin E Cap/Tab - Prostate Cancer, Uterine Cancer
Phase 1 / Phase 2Not yet recruitingUniversity of Nebraska2002026-12-012026-10-08
Swabs in Screening for HPV (SWISH)
Self-collected anal swab - Anal Cancer, Human Papilloma Virus (HPV)
Not applicableNot yet recruitingKirby Institute7002026-11-012026-08-27
Epidemiology of Anal Human Papillomavirus Carriage in Female Solid Organ Transplant Recipients With More Than 10 Years of Immunosuppression
Anal Self-Sampling for High-Risk HPV Detection - Human Papillomavirus Infection, Anal HPV Infection
Not applicableNot yet recruitingUniversity Hospital, Montpellier1902026-10-012026-10-05
Mind-Body Sexual Well-Being Program for Female GI Cancer Survivors
Mind-Body Group Intervention, Enhanced Usual Care Control (EUCC) - Colorectal Cancer (Diagnosis), Anal Cancer
Not applicableNot yet recruitingMassachusetts General Hospital1002026-10-012026-09-08
Phase 2 Study of Pembrolizumab and Lenvatinib in Anal Squamous Cell Cancer
Lenvatinib, Pembrolizumab - Anal Squamous Cell Carcinoma
Phase 2Not yet recruitingUniversity of Texas Southwestern Medical Center172026-09-302026-07-02
Blood Biomarkers Based Screening for HPV-driven OPC
HPV16-E6 serology and HPV ctDNA - Head and Neck Squamous Cell Carcinoma, Anal Cancer
Not applicableNot yet recruitingUNICANCER100002026-09-012026-05-26
Shortening Radiation Course Duration Using Simultaneous Integrated Boost With Lower Intensity Elective Nodal Dosing and Concurrent Chemotherapy for High-Risk Anal Squamous Cell Carcinoma
Hypofractionated Radiation Therapy - Anal Cancer
Phase 2Enrolling by invitationUniversity of Vermont Medical Center242026-08-262026-09-15
GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity
GLP-1 receptor agonist therapy - Morbid Obesity, Anorectal Diseases
Not yet recruitingGazi University1002026-08-012026-06-25
AI-Assisted Written Information in Chronic Anal Fissure
AI-assisted written patient information, Standardized verbal counseling - Chronic Anal Fissure
Not applicableRecruitingSanliurfa Education and Research Hospital2202026-07-152026-09-09
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
IDP-001 - Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1 / Phase 2RecruitingInduPro, Inc.1322026-07-082026-09-03
Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers
HIV (Human Immunodeficiency Virus), AIDS
Not yet recruitingShenzhen Third People's Hospital10002026-07-012026-07-10
ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer
HPV ctDNA Response based radiation, Chemotherapy, Retifanlimab - Anal Cancer, HPV-Related Carcinoma
Phase 2RecruitingJennifer Dorth332026-06-192026-08-14
Topical Nitroglycerin Versus Lateral Internal Sphincterotomy for Chronic Anal Fissure
Topical 0.2% Glyceryl Trinitrate (Nitroglycerin) Ointment, Lateral Internal Sphincterotomy - Chronic Anal Fissure
Not applicableCompletedSheikh Zayed Federal Postgraduate Medical Institute722026-06-152026-10-21
CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV
PDS0101 - HPV Associated Cancers, HIV (Human Immunodeficiency Virus)
Phase 2WithdrawnUniversity of California, San Diego2026-04-302026-08-19
Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal Study
Assessment of sexual quality of life - Pelvic Cancer, Anal Cancer
Not applicableNot yet recruitingInstitut du Cancer de Montpellier - Val d'Aurelle422026-04-022026-04-13
The Impact of Perianal Disease on Patient's Sex Life
Patient Reported Outcome Assessment (Questionnaires) - Perianal Crohn Disease, Perianal Fistula
RecruitingAHEPA University Hospital602026-03-312026-04-09
Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell Carcinoma
Intensity-Modulated Radiotherapy (IMRT), Capecitabine, Sintilimab - Anal Squamous Cell Carcinoma, Limited-stage
Phase 3RecruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences3502026-03-172026-07-09
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Biospecimen Collection, Prasterone, Survey Administration - Anal Carcinoma, Cervical Carcinoma
Phase 2RecruitingOhio State University Comprehensive Cancer Center252026-03-122026-04-21
Distance-Based Exercise to Preserve Function and Prevent Disability
Exercise intervention, Telemedicine, Aerobic Exercise Intervention - Localized Malignant Solid Neoplasm, Anal Cancer
Not applicableRecruitingAlliance for Clinical Trials in Oncology1042026-02-112026-10-02

Showing 20 of 361. Sign in to see all of them.

Narrower conditions

Anus Neoplasms (294)  ·  Uterine Cervical Neoplasms (86)  ·  Fissure in Ano (62)  ·  Rectal Neoplasms (57)  ·  Stomach Neoplasms (52)  ·  Pancreatic Neoplasms (47)  ·  Esophageal Neoplasms (46)  ·  Vulvar Neoplasms (46)  ·  Colonic Neoplasms (45)  ·  Penile Neoplasms (40)  ·  Breast Neoplasms (36)  ·  Neoplasms (36)  ·  Squamous Cell Carcinoma of Head and Neck (34)  ·  Vaginal Neoplasms (33)  ·  Prostatic Neoplasms (32)

Broader conditions

Digestive System Diseases (361)  ·  Gastrointestinal Diseases (360)  ·  Intestinal Diseases (360)  ·  Rectal Diseases (358)  ·  Digestive System Neoplasms (294)  ·  Neoplasms by Site (294)  ·  Intestinal Neoplasms (293)  ·  Gastrointestinal Neoplasms (287)  ·  Colorectal Neoplasms (264)  ·  Neoplasms (260)  ·  Rectal Neoplasms (237)  ·  Urogenital Diseases (152)  ·  Genital Diseases (145)  ·  Female Urogenital Diseases and Pregnancy Complications (110)

Interventions

Fluorouracil (26)  ·  Mitomycin (18)  ·  Radiotherapy (18)  ·  Capecitabine (13)  ·  Cisplatin (12)  ·  pembrolizumab (11)  ·  Cyclophosphamide (9)  ·  Magnetic Resonance Spectroscopy (9)  ·  Biopsy (8)  ·  Paclitaxel (8)  ·  Radiation (8)  ·  Carboplatin (7)  ·  Drug Therapy (7)  ·  Nivolumab (7)  ·  Specimen Handling (7)

Sponsors

National Cancer Institute (NCI) (22)  ·  AIDS Malignancy Consortium (11)  ·  M.D. Anderson Cancer Center (8)  ·  Mansoura University (8)  ·  Stanford University (6)  ·  University Health Network, Toronto (5)  ·  Aarhus University Hospital (4)  ·  Medical College of Wisconsin (4)  ·  Memorial Sloan Kettering Cancer Center (4)  ·  Sahlgrenska University Hospital (4)  ·  UNICANCER (4)  ·  Alliance for Clinical Trials in Oncology (3)  ·  Beijing Health Guard Biotechnology, Inc (3)  ·  ECOG-ACRIN Cancer Research Group (3)  ·  Glaxo Wellcome (3)

Countries

United States (166)  ·  France (26)  ·  China (18)  ·  Canada (17)  ·  Italy (14)  ·  United Kingdom (14)  ·  Spain (13)  ·  Australia (12)  ·  Denmark (12)  ·  Sweden (12)  ·  Egypt (10)  ·  Germany (10)  ·  Belgium (7)  ·  Brazil (7)  ·  Norway (7)

Top investigators

Joel Palefsky, MD (4)  ·  Alan Nyitray, PhD (3)  ·  Cathy Eng (3)  ·  Mark Lane Welton (3)  ·  Yongjiang Liu, Bachelor (3)  ·  Charalampos Floudas, M.D. (2)  ·  Christian S Hinrichs, MD (2)  ·  Elizabeth Stier, MD (2)  ·  Irving Salit, MD (2)  ·  Jaffer A. Ajani, MD (2)  ·  Jervoise Andreyev, MD (2)  ·  Jian Zhang, Doctor (2)  ·  Joseph A. Sparano, MD (2)  ·  Lakshmi Rajdev (2)

Results publications

PMID 23578724, PMID 28223062, PMID 11668104, PMID 18430910, PMID 20354531, PMID 20956625, PMID 28453692, PMID 29779044, PMID 31534737, PMID 32530769, PMID 8874455, PMID 10395629, PMID 10626860, PMID 11052511, PMID 12041718, PMID 12194122, PMID 12196376, PMID 12393999, PMID 13680282, PMID 15129311, PMID 15479678, PMID 15540293, PMID 15629599, PMID 15906136, PMID 15933795, PMID 15949202, PMID 16254521, PMID 17096178, PMID 17103253, PMID 17665247, PMID 18085337, PMID 18191265, PMID 18470481, PMID 18629515, PMID 18637925, PMID 18954306, PMID 19139424, PMID 19225835, PMID 19643599, PMID 19690306, PMID 19801930, PMID 20068553, PMID 20177691, PMID 20187965, PMID 20339140, PMID 20436836, PMID 20564111, PMID 20628272, PMID 20852198, PMID 20940607

NIH funding

U01CA121947 (8), UM1CA121947 (5), 2018 (4), U10CA180820 (4), 2015 (2), 2019 (2), P30CA015083 (2), P30CA016672 (2), P30CA068485 (2), K01AT008219 (1), N01CM00032 (1), N01CM00038 (1), N01CM00039 (1), N01CM00071 (1), N01CM00099 (1)